These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 6147789)
1. Melperone in low doses in anxious neurotic patients. A double-blind placebo-controlled clinical study. Pöldinger WJ Neuropsychobiology; 1984; 11(3):181-6. PubMed ID: 6147789 [TBL] [Abstract][Full Text] [Related]
2. A comparison of two doses of melperone, an atypical antipsychotic drug, in the treatment of schizophrenia. Sumiyoshi T; Jayathilake K; Meltzer HY Schizophr Res; 2003 Jul; 62(1-2):65-72. PubMed ID: 12765745 [TBL] [Abstract][Full Text] [Related]
3. A clinical comparison of melperone and placebo in schizophrenic women on a milieu therapeutic ward. Härnryd C; Bjerkenstedt L; Gullberg B Acta Psychiatr Scand Suppl; 1989; 352():40-7. PubMed ID: 2573240 [TBL] [Abstract][Full Text] [Related]
4. A double-blind study of melperone and placebo in hospitalized chronic alcoholics in postintoxication phase. Carlsson C; Gullberg B; Höstery U; Christensson E Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):341-5. PubMed ID: 39900 [TBL] [Abstract][Full Text] [Related]
5. A double blind study with melperone and placebo in the treatment of chronic alcoholics. Carlsson C; Gullberg B Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):331-2. PubMed ID: 352974 [TBL] [Abstract][Full Text] [Related]
6. Melperone in the treatment of neuroleptic-resistant schizophrenia. Meltzer HY; Sumiyoshi T; Jayathilake K Psychiatry Res; 2001 Dec; 105(3):201-9. PubMed ID: 11814539 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). Thase ME; Macfadden W; Weisler RH; Chang W; Paulsson B; Khan A; Calabrese JR; J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817 [TBL] [Abstract][Full Text] [Related]
15. Double-blind randomized trial of the benzodiazepine derivative metaclazepam as compared with placebo treatment of outpatients with anxiety syndromes. Laakmann G; Blaschke D; Hippius H; Schewe S Pharmacopsychiatry; 1988 May; 21(3):136-43. PubMed ID: 2900514 [TBL] [Abstract][Full Text] [Related]
16. Two 6-week, randomized, double-blind, placebo-controlled studies of ziprasidone in outpatients with bipolar I depression: did baseline characteristics impact trial outcome? Lombardo I; Sachs G; Kolluri S; Kremer C; Yang R J Clin Psychopharmacol; 2012 Aug; 32(4):470-8. PubMed ID: 22722504 [TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of propranolol, chlordiazepoxide, and placebo in the treatment of anxiety: a double-blind trial. Meibach RC; Dunner D; Wilson LG; Ishiki D; Dager SR J Clin Psychiatry; 1987 Sep; 48(9):355-8. PubMed ID: 3305488 [TBL] [Abstract][Full Text] [Related]
18. Comparison of efficacy of a new butyrophenone derivative, timiperone and perphenazine in schizophrenia by a multicentre controlled study. Takahashi R; Inanaga K; Samejima K; Sarai K; Asada S; Otsuki S; Nakano S J Int Med Res; 1982; 10(4):257-67. PubMed ID: 6126413 [TBL] [Abstract][Full Text] [Related]
19. Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study. Bandelow B; Chouinard G; Bobes J; Ahokas A; Eggens I; Liu S; Eriksson H Int J Neuropsychopharmacol; 2010 Apr; 13(3):305-20. PubMed ID: 19691907 [TBL] [Abstract][Full Text] [Related]
20. Antiarrhythmic properties of a neuroleptic butyrophenone, melperone, in acute myocardial infarction. A double-blind trial. Møgelvang JC; Petersen EN; Folke PE; Ovesen L Acta Med Scand; 1980; 208(1-2):61-4. PubMed ID: 7435249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]